Data Science Funding Announcements & Notices

Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.

Title FOA Organization Release Date Expire Date Purpose
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) PAR-21-206 NCI The purpose of this Funding Opportunity Announcement (FOA) is to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in… More
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) RFA-CA-21-013 NCI The purpose of this Funding Opportunity Announcement (FOA) is to invite exploratory/developmental research grant applications (R21) for the development of innovative methods and algorithms in… More
Notice of Special Interest (NOSI): Geospatial Approaches in Cancer Control and Population Sciences NOT-CA-20-004 NCI Notice Special Interest NOSI): Geospatial Approaches Cancer Control Population Sciences Notice Number: NOT-CA-20-004 Key Dates Release Date: October 22, 2019 First Available Due Date: February 05,… More
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) RFA-CA-21-006 NCI This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies that improve the… More
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) PAR-19-339 NCI This FOA encourages the integration of cognitive neuroscience approaches to improve traditional assessment of acute and chronic cognitive changes following cancer treatment for non-central nervous… More
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional) PA-18-902 NCI The purpose of this funding opportunity announcement (FOA) is twofold: 1. to accelerate translational and clinical Phase I and II a/b safety and efficacy studies for substantiating measurable… More
New Informatics Tools and Methods to Enhance U.S. Cancer Surveillance Research (U01 Clinical Trial Optional) PAR-20-170 NCI The goal of this Funding Opportunity Announcement (FOA) is to advance surveillance science by supporting the development of new and innovative tools and methods for more efficient, detailed, timely,… More
Notice of Special Interest (NOSI): Use of Biological Information to Understand How the Interplay of Environmental Exposures and Genes Influences Cancer Risk NOT-CA-20-002 NCI Notice Special Interest NOSI): of Biological Information Understand the Interplay Environmental Exposures Genes Influences Cancer Risk Notice Number: NOT-CA-20-002 Key Dates Release Date: October 9… More
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional) PAR-21-138 NCI The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs). By providing such an opportunity for… More
Neural Regulation of Cancer (R21 Clinical Trial Not Allowed) PAR-19-354 NCI This Funding Opportunity Announcement (FOA) encourages collaborative, transdisciplinary research with both neuroscience and cancer elements, which together will advance current understanding of the… More
Updated: